12-Month Effectiveness and Tolerability of Brivaracetam in the Real-World: The International EXPERIENCE Pooled Analysis

Author:Villanueva, Vicente   D'Souza, Wendyl   Faught, Edward   Klein, Pavel   Reuber, Markus   Rosenow, Felix   Salas-Puig, Javier   Soto Insuga, Victor   Strzelczyk, Adam   Szaflarski, Jerzy P.   Besson, Herve   Daniels, Tony   Floricel, Florin   Laloyaux, Cedric   Sendersky, Veronica   Zhou, Sophia   Steinhoff, Bernhard J.   

Session Name:P11: Epilepsy/Clinical Neurophysiology (EEG): ASMs Clinical Trial 1  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:P11.003  

Author Institution:Hospital Universitario y Politécnico La Fe, Valencia, Spain, Valencia, Spain  Department of Medicine, St Vincent’s Hospital Melbourne, The University of Melbourne, Melbourne, Australia, Melbourne, Australia  Emory Epilepsy Center, Atlanta, GA, USA, Atlanta, GA  Mid-Atlantic Epilepsy and Sleep Center, Bethesda, MD, USA, Bethesda, MD  The University of Sheffield, Sheffield, UK, Sheffield, United Kingdom  Epilepsy Center Frankfurt Rhine-Main, Center of Neurology and Neurosurgery, Frankfurt, Germany, Frankfurt am Main, Germany  Universitari Vall d’Hebron, Barcelona, Spain, Barcelona, Spain  Pediatric Neurology, Hospital Universitario Infantil Niño Jesús, Madrid, Spain, Madrid, Spain  Epilepsy Center Frankfurt Rhine-Main, Center of Neurology and Neurosurgery, Frankfurt, Germany, Frankfurt, Germany  UAB Epilepsy Center, Birmingham, AL, USA, Birmingham, AL  UCB Pharma, Breda, Netherlands, Breda, Netherlands  UCB Pharma, Morrisville, NC, USA, Morrisville, NC  UCB Pharma, Monheim am Rhein, Germany, Monheim Am Rhein, Germany  UCB Pharma, Brussels, Belgium, Brussels, Belgium  Kork Epilepsy Center, Kehl-Kork and Medical Faculty, University of Freiburg, Freiburg, Germany, Kork, Germany